FDA Inspection 1245469 — Main Oxy NY, Inc
The FDA completed an inspection of Main Oxy NY, Inc on Aug 5, 2024 in Buffalo, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 5, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Buffalo, NY (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1105 | 21 CFR 211.22(d) | Procedures not in writing, fully followed |
| 1632 | 21 CFR 211.130(c) | Lot or control number assigned |
| 2027 | 21 CFR 211.192 | Investigations of discrepancies, failures |